Creative Biolabs has drawn attention to a set of research products and services aimed at improving functional evaluation and experimental control in two distinct but demanding fields: complement biology and droplet microfluidics. The company’s announcement, made on October 28, 2026, underscores the importance of reliable tools and well-defined experimental conditions for translational researchers who need more than a single endpoint from their experiments.
In complement therapeutics, challenges such as assay variability and limited functional readouts can complicate data interpretation. Binding data alone may not reveal whether a drug candidate influences pathway activity at the functional level. To address this, Creative Biolabs offers its CH50 functional test kit, a hemolysis-based assay for measuring classical complement pathway activity through antibody-sensitized red blood cell lysis. The kit supports serum or plasma samples from multiple species, including humans, mice, and rats, and is suitable for studies involving complement inhibitors or activators.
For more detailed functional characterization, the company provides a hemolysis inhibition profiling service that uses hemolytic readouts to assess changes in complement-mediated red blood cell lysis after inhibitor treatment. By examining concentration-dependent inhibition responses, the service can aid inhibitor potency assessment, comparative activity profiling, and mechanism-of-action investigations. Depending on research goals, classical or alternative pathway assays may be incorporated to address pathway-specific questions. Such functional readouts can help distinguish target-binding activity from downstream functional inhibition, giving researchers a broader view of how candidate molecules interact with the complement cascade.
In microfluidics, researchers face the challenge of generating droplets with suitable consistency for encapsulation, screening, and compartmentalized assay workflows. Creative Biolabs’ flow focusing droplet generation chip uses a flow-focusing configuration in which interactions between a continuous phase and a dispersed phase promote droplet formation within microchannels. The PDMS-based chip is designed for water-in-oil and oil-in-water droplet generation and can also be applied to single-cell encapsulation research. Such systems may help researchers establish more controlled experimental conditions while adapting droplet generation parameters to specific study requirements.
Although complement testing and droplet microfluidics address different experimental needs, both reflect the importance of selecting appropriate research tools and measurable endpoints. By offering functional complement assay solutions alongside microfluidic research tools, Creative Biolabs aims to support researchers working to refine workflows, broaden functional characterization, and choose research formats suited to different biological questions. All referenced products and services are intended for research use only and are not for diagnostic or therapeutic use in humans.
